Bio-Techne TECH
NASDAQ TECH
$72.43 -0.02 (-0.03%)
As of: Sep 4, 2026 · 3:19 PM EDT

Bio-Techne (TECH) Gross Profit (QoQ) (2009 - 2026)

Analysis

Bio-Techne (TECH) Gross Profit (QoQ) (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn
5 Revolution Medicines 43.98 Bn 43.98 Bn -
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn -
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn
10 Bio-Techne 11.29 Bn 11.03 Bn 211.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.49%
Mar 31, 2026 8.89%
Dec 31, 2025 1.68%
Sep 30, 2025 -5.38%
Jun 30, 2025 -7.34%
Mar 31, 2025 10.66%
Dec 31, 2024 5.94%
Sep 30, 2024 -10.00%
Jun 30, 2024 -0.61%
Mar 31, 2024 15.86%
Dec 31, 2023 -4.65%
Sep 30, 2023 -9.53%
Jun 30, 2023 1.25%
Mar 31, 2023 10.25%
Dec 31, 2022 2.10%
Sep 30, 2022 -10.36%
Jun 30, 2022 -0.55%
Mar 31, 2022 9.67%
Dec 31, 2021 7.42%
Sep 30, 2021 -2.81%